MedPath

Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort

Not Applicable
Not yet recruiting
Conditions
COPD Exacerbation
Registration Number
NCT05762861
Lead Sponsor
University of Minho
Brief Summary

The aim of our study is to assess the feasibility and benefits of the implementation of an interactive telemonitoring system for earlier detection of COPD exacerbations in a community cohort preventing further deterioration requiring hospital admissions.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Diagnosis of COPD
  • Aged 40 years or above
  • Must be enrolled in health centres from Braga
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Impact of the programme - satisfaction level18 months

Measurement tool - questionnaire

Number of COPD exacerbation with hospital admission18 months
Quality of Life using St. George's Respiratory Questionnaire18 months

Scores range from 0 (no effect on quality of life) to a maximum score of 100 (maximum perceived distress). A higher score means a poorer quality of life

Impact of the programme - rate of compliance18 months

Measurement tool - questionnaire

Impact of the programme - % of retention of participating patients18 months

Measurement tool - questionnaire

Impact of COPD on patient's life using COPD Assessment Test (CAT)18 months

Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.

Number of COPD exacerbation managed at home18 months
Secondary Outcome Measures
NameTimeMethod
Dyspnoea level (mMRC)18 months
Pulmonary function (FEV1 and FEV1/ FVC ratio after BD)18 months
Changes in GOLD classification18 months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.